{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:04:37Z","timestamp":1790395477566,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","award":["IIR-ARG-002876"],"award-info":[{"award-number":["IIR-ARG-002876"]}],"id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-01908-9","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T08:02:07Z","timestamp":1711008127000},"page":"625-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathogenic pathways of renal damage in Fabry nephropathy: interplay between immune cell infiltration, apoptosis and fibrosis"],"prefix":"10.1093","volume":"37","author":[{"given":"Constanza","family":"Bondar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de los Angeles","family":"de Bolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Feriozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8138-3087","authenticated-orcid":false,"given":"Paula Adriana","family":"Rozenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"5082","key":"1908_CR1","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1136\/bmj.1.5082.1266","volume":"1","author":"JR Colley","year":"1958","unstructured":"Colley JR, Miller DR, Hutt MS, Wallace HJ, DE Wardener HE (1958) The renal lesion in angiokeratoma corporis diffusum. BMJ 1(5082):1266\u20131268. https:\/\/doi.org\/10.1136\/bmj.1.5082.1266","journal-title":"BMJ"},{"issue":"5","key":"1908_CR2","doi-asserted-by":"publisher","first-page":"e1666","DOI":"10.1002\/mgg3.1666","volume":"9","author":"DP Germain","year":"2021","unstructured":"Germain DP, Moiseev S, Su\u00e1rez-Obando F (2021) The benefits and challenges of family genetic testing in rare genetic diseases-lessons from Fabry disease. Mol Genet Genom 9(5):e1666. https:\/\/doi.org\/10.1002\/mgg3.1666","journal-title":"Mol Genet Genom"},{"key":"1908_CR3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.12.032","author":"C T\u00f8ndel","year":"2008","unstructured":"T\u00f8ndel C, Bostad L, Hirth A, Svarstad E (2008) Renal biopsy findings in children and adolescents with fabry disease and minimal albuminuria. Am J Kidney Dis. https:\/\/doi.org\/10.1053\/j.ajkd.2007.12.032","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1908_CR4","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.ymgme.2012.11.064","volume":"108","author":"P De Francesco","year":"2013","unstructured":"De Francesco P, Mucci JM, Ceci R, Rozenfeld PA (2013) Globotriaosylceramide (Gb3) induces a proinflammatory cytokine profile in dendritic cells and macrophages: consequences for Fabry disease. Mol Genet Metab 108(2):S33. https:\/\/doi.org\/10.1016\/j.ymgme.2012.11.064","journal-title":"Mol Genet Metab"},{"issue":"9","key":"1908_CR5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10157-021-02058-z","volume":"25","author":"S Feriozzi","year":"2021","unstructured":"Feriozzi S, Rozenfeld P (2021) Pathology and pathogenic pathways in fabry nephropathy. Clin Exp Nephrol 25(9):925\u2013934. https:\/\/doi.org\/10.1007\/s10157-021-02058-z","journal-title":"Clin Exp Nephrol"},{"issue":"20","key":"1908_CR6","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1093\/hmg\/ddv291","volume":"24","author":"MD Sanchez-Ni\u00f1o","year":"2015","unstructured":"Sanchez-Ni\u00f1o MD, Carpio D, Sanz AB, Ruiz-Ortega M, Mezzano S, Ortiz A (2015) Lyso-Gb3 activates Notch1 in human podocytes. Hum Mol Genet 24(20):5720\u20135732. https:\/\/doi.org\/10.1093\/hmg\/ddv291","journal-title":"Hum Mol Genet"},{"key":"1908_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.10.010","author":"PA Rozenfeld","year":"2020","unstructured":"Rozenfeld PA, de los Angeles Bolla M, Quieto P, Pisani A, Feriozzi S, Neuman P, Bondar C (2020) Pathogenesis of Fabry nephropathy: the pathways leading to fibrosis. Mol Genet Metabol. https:\/\/doi.org\/10.1016\/j.ymgme.2019.10.010","journal-title":"Mol Genet Metabol"},{"issue":"9","key":"1908_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneph.2014.114","volume":"10","author":"XM Meng","year":"2014","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY (2014) Inflammatory processes in renal fibrosis. Nat Rev Nephrol 10(9):493\u2013503. https:\/\/doi.org\/10.1038\/nrneph.2014.114","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"1908_CR9","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.4049\/jimmunol.1701135","volume":"199","author":"K Ley","year":"2017","unstructured":"Ley K (2017) M1 means kill; M2 means heal. J Immunol 199(7):2191\u20132193. https:\/\/doi.org\/10.4049\/jimmunol.1701135","journal-title":"J Immunol"},{"issue":"3","key":"1908_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PMK Tang","year":"2019","unstructured":"Tang PMK, Nikolic-Paterson DJ, Lan HY (2019) Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol 15(3):144\u2013158. https:\/\/doi.org\/10.1038\/s41581-019-0110-2","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1908_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.4049\/jimmunol.1200662","volume":"16","author":"X Ding","year":"2013","unstructured":"Ding X, Boney-montoya J, Owen BM, Bookout AL, Coate C, Mangelsdorf DJ, Kliewer SA (2013) Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 16(3):387\u2013393. https:\/\/doi.org\/10.4049\/jimmunol.1200662","journal-title":"J Immunol"},{"issue":"5","key":"1908_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/MAJ.0000000000000569","volume":"350","author":"J Li","year":"2015","unstructured":"Li J, Liu CH, Xu DL, Gao B (2015) Significance of CD163-positive macrophages in proliferative glomerulonephritis. Am J Med Sci 350(5):387\u2013392. https:\/\/doi.org\/10.1097\/MAJ.0000000000000569","journal-title":"Am J Med Sci"},{"issue":"8","key":"1908_CR13","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/ndt\/gfw260","volume":"32","author":"CQF Klessens","year":"2017","unstructured":"Klessens CQF, Zandbergen M, Wolterbeek R, Bruijn JA, Rabelink TJ, Bajema IM, Ijpelaar DHT (2017) Macrophages in diabetic nephropathy in patients with type 2 diabetes. Nephrol Dial Transpl 32(8):1322\u20131329. https:\/\/doi.org\/10.1093\/ndt\/gfw260","journal-title":"Nephrol Dial Transpl"},{"key":"1908_CR14","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00414.2012","author":"G Campanholle","year":"2013","unstructured":"Campanholle G, Ligresti G, Gharib SA, Duffield JS (2013) Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol. https:\/\/doi.org\/10.1152\/ajpcell.00414.2012","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"1908_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.trsl.2014.07.010","volume":"165","author":"SY Lee","year":"2015","unstructured":"Lee SY, Kim SI, Choi ME (2015) Therapeutic targets for treating fibrotic kidney diseases. Transl Res 165(4):512\u2013530. https:\/\/doi.org\/10.1016\/j.trsl.2014.07.010","journal-title":"Transl Res"},{"issue":"11","key":"1908_CR16","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1152\/ajprenal.00509.2013","volume":"306","author":"K Omote","year":"2014","unstructured":"Omote K, Gohda T, Murakoshi M, Sasaki Y, Kazuno S, Fujimura T et al (2014) Role of the TNF pathway in the progression of diabetic nephropathy in KK-Ay mice. Am J Physiol Renal Physiol 306(11):1335\u20131347. https:\/\/doi.org\/10.1152\/ajprenal.00509.2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"1908_CR17","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/ndt\/gfq310","volume":"25","author":"I Idasiak-Piechocka","year":"2010","unstructured":"Idasiak-Piechocka I, Oko A, Pawliczak E, Kaczmarek E, Czekalsk S (2010) Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis. Nephrol Dial Transpl 25(12):3948\u20133956. https:\/\/doi.org\/10.1093\/ndt\/gfq310","journal-title":"Nephrol Dial Transpl"},{"issue":"15 Suppl","key":"1908_CR18","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1097\/01.ASN.0000093460.24823.5B","volume":"15","author":"FN Ziyadeh","year":"2004","unstructured":"Ziyadeh FN (2004) No title. J Am Soc Nephrol 15(15 Suppl):S55\u2013S57","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1908_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.23876\/j.krcp.20.264","volume":"40","author":"S Chung","year":"2021","unstructured":"Chung S, Son M, Chae Y, Oh S, Koh ES, Kim YK, Shin SJ, Park CW, Jung SC, Kim HS (2021) Fabry disease exacerbates renal interstitial fibrosis after unilateral ureteral obstruction via impaired autophagy and enhanced apoptosis. Kidney Res Clin Pract 40(2):208\u2013219. https:\/\/doi.org\/10.23876\/j.krcp.20.264","journal-title":"Kidney Res Clin Pract"},{"issue":"4","key":"1908_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/cells8040327","volume":"8","author":"HY Song","year":"2019","unstructured":"Song HY, Chien CS, Yarmishyn AA, Chou SJ, Yang YP, Wang ML, Wang CY, Leu HB, Yu WC, Chang YL, Chiou SH (2019) Generation of GLA-knockout human embryonic stem cell lines to model autophagic dysfunction and exosome secretion in fabry disease-associated hypertrophic cardiomyopathy. Cells 8(4):327. https:\/\/doi.org\/10.3390\/cells8040327","journal-title":"Cells"},{"issue":"6","key":"1908_CR21","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s11255-023-03468-6","volume":"55","author":"K Turkmen","year":"2023","unstructured":"Turkmen K, Karaselek MA, Celik SC, Esen HH, Ozer H, Baloglu I et al (2023) Could immune cells be associated with nephropathy in Fabry disease patients? Int Urol Nephrol 55(6):1575\u20131588. https:\/\/doi.org\/10.1007\/s11255-023-03468-6","journal-title":"Int Urol Nephrol"},{"issue":"December 2017","key":"1908_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","volume":"820","author":"W Lv","year":"2018","unstructured":"Lv W, Booz GW, Wang Y, Fan F, Roman RJ (2018) Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol 820(December 2017):65\u201376. https:\/\/doi.org\/10.1016\/j.ejphar.2017.12.016","journal-title":"Eur J Pharmacol"},{"issue":"Suppl J","key":"1908_CR23","first-page":"57","volume":"14","author":"CG Brilla","year":"1993","unstructured":"Brilla CG, Reams GP, Maisch B, Weber KT (1993) Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix. Eur Heart J 14(Suppl J):57\u201361","journal-title":"Eur Heart J"},{"issue":"6","key":"1908_CR24","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.kint.2017.12.016","volume":"93","author":"J Barrera-Chimal","year":"2018","unstructured":"Barrera-Chimal J, Estrela GR, Lechner SM, Giraud S, El Moghrabi S, Kaaki S, Kolkhof P, Hauet T, Jaisser F (2018) The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling. Kidney Int 93(6):1344\u20131355. https:\/\/doi.org\/10.1016\/j.kint.2017.12.016. (Epub 2018 Mar 13)","journal-title":"Kidney Int"},{"key":"1908_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fphar.2017.00313","volume":"8","author":"GH Tesch","year":"2017","unstructured":"Tesch GH, Young MJ (2017) Mineralocorticoid receptor signaling as a therapeutic target for renal and cardiac fibrosis. Front Pharmacol 8:313. https:\/\/doi.org\/10.3389\/fphar.2017.00313","journal-title":"Front Pharmacol"},{"key":"1908_CR26","doi-asserted-by":"publisher","first-page":"110908","DOI":"10.1016\/j.diabres.2023.110908","volume":"204","author":"HJL Heerspink","year":"2023","unstructured":"Heerspink HJL, Birkenfeld AL, Cherney DZI, Colhoun HM, Ji L, Mathieu C, Groop PH, Pratley RE, Rosas SE, Rossing P, Skyler JS, Tuttle KR, Lawatscheck R, Scott C, Edfors R, Scheerer MF, Kolkhof P, McGill JB (2023) Rationale and design of a randomized phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: the FINE-ONE trial. Diabetes Res Clin Pract 204:110908. https:\/\/doi.org\/10.1016\/j.diabres.2023.110908","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1908_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-8-116","volume":"8","author":"F Weidemann","year":"2013","unstructured":"Weidemann F, Sanchez-Ni\u00f1o MD, Politei J, Oliveira JP, Wanner C, Warnock DG, Ortiz A (2013) Fibrosis: a key feature of Fabry disease with potential therapeutic implications. Orphanet J Rare Dis 8(1):1\u201312. https:\/\/doi.org\/10.1186\/1750-1172-8-116","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1908_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1681\/ASN.2019050497","volume":"31","author":"B Najafian","year":"2020","unstructured":"Najafian B, T\u00f8ndel C, Svarstad E, Gubler MC, Oliveira JP, Mauer M (2020) Accumulation of globotriaosylceramide in podocytes in fabry nephropathy is associated with progressive podocyte loss. J Am Soc Nephrol 31(4):865\u2013875. https:\/\/doi.org\/10.1681\/ASN.2019050497","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1908_CR29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1159\/000478070","volume":"42","author":"Y Zhuang","year":"2017","unstructured":"Zhuang Y, Zhao F, Liang J, Deng X, Zhang Y, Ding G et al (2017) Activation of COX-2\/mPGES-1\/PGE2 cascade via NLRP3 inflammasome contributes to albumin-induced proximal tubule cell injury. Cell Physiol Biochem 42(2):797\u2013807. https:\/\/doi.org\/10.1159\/000478070","journal-title":"Cell Physiol Biochem"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01908-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-01908-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01908-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:45Z","timestamp":1777564425000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/3\/625\/8306646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["1908"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-01908-9","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PN, AP, SF and PR have received travel grants, research grants and\/or consulting fees from Takeda and Amicus.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The procedures were in accordance with the ethical standards of the Ethical Committee of Framingham (La Plata, Argentina) and with the Helsinki Declaration of 1975, as revised in 2013.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures were approved by the Ethical Committee of Framingham (La Plata, Argentina) International review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"All patients provided written informed consent to participate in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}